Budgetary Impact Analysis of Reimbursement Varenicline for the Smoking-Cessation Treatment in Patients with Cardiovascular Diseases, Chronic Obstructive Pulmonary Disease or Type-2 Diabetes Mellitus: A National Health System Perspective

By  

European Addiction Research, Vol. 23, Iss. 1, 2016-10 ,pp. : 7-18

Karger

Access to resources Recommend Favorite

Effects of active and passive smoking on the development of cardiovascular disease as assessed by a carotid intima‐media thickness examination in patients with type 2 diabetes mellitus

By  

CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY (ELECTRONIC), Vol. 42, Iss. 5, 2015-05 ,pp. : 444-450

John Wiley & Sons Inc

Access to resources Recommend Favorite

Fibrates in the prevention of cardiovascular disease in patients with type 2 diabetes mellitus: meta-analysis of randomised controlled trials

By Allemann Sabin   Diem Peter   Egger Matthias   Christ Emanuel R.   Stettler Christoph  

Current Medical Research and Opinion, Vol. 22, Iss. 3, 2006-03 ,pp. : 617-623

Informa Healthcare

Access to resources Recommend Favorite

Comparative effects of sitagliptin and metformin in patients with type 2 diabetes mellitus: a meta-analysis

By Du Qiang   Wu Bo   Wang Yan-Jun   Yang Sheng   Zhao Yue-Yang   Liang Yuan-yuan  

Current Medical Research and Opinion, Vol. 29, Iss. 11, 2013-11 ,pp. : 1487-1494

Informa Healthcare

Access to resources Recommend Favorite

Albuminuria Is Not Associated with Bacteriuria in Patients with Type 2 Diabetes Mellitus: A Meta-Analysis of Observational Studies

By  

Nephron Clin Pract, Vol. 120, Iss. 1, 2012-01 ,pp. : c54-c58

Karger

Access to resources Recommend Favorite